cvi42 Auto Imaging vs Cardiomo

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Circle Cardiovascular Imaging
VS
by Cardiomo, Inc.

AI Verdict

Tool A (cvi42 Auto Imaging) is an AI-powered software for comprehensive analysis of cardiovascular MR and CT images, primarily used by clinicians for precise diagnosis and streamlined workflows within a hospital or clinical setting. Tool B (Cardiomo) is a medical-grade wearable device and AI-powered platform for continuous and remote heart health monitoring, designed for patients and caregivers to detect cardiovascular diseases and provide timely alerts. While both focus on cardiovascular health and leverage AI, their core functionalities, deployment, and target users differ significantly, making them adjacent rather than direct competitors.

Choose cvi42 Auto Imaging if…

Choose cvi42 Auto Imaging if your institution requires comprehensive, AI-powered analysis of cardiovascular MR and CT images for precise diagnosis, plaque quantification, and streamlined clinical workflows. It is ideal for cardiologists and radiologists who need to perform detailed quantitative assessments, 3D visualizations, and generate smart reports within an on-premise, networked environment, ensuring data control and security.

View cvi42 Auto Imaging →

Choose Cardiomo if…

Choose Cardiomo if you need a medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, particularly for detecting cardiovascular diseases and providing timely alerts to users and caregivers. This solution is best suited for individuals or healthcare providers focused on proactive monitoring, early disease detection, and remote patient management, especially for conditions like arrhythmias or potential cardiac events.

View Cardiomo →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature cvi42 Auto Imaging Cardiomo
Pricing Contact for pricing Contact for pricing
Deployment On-premise, Stand-alone, Networked environment. Cloud compatibility is mentioned as a feature, but recent FDA clearances for modules like cvi42 | Plaque emphasize on-premise deployment for data control. Cloud-based with wearable device and mobile app
FDA Status 1 AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

cvi42 Auto Imaging

cvi42 Auto Imaging emphasizes a seamless user experience, aiming to deliver superior patient outcomes over software complexity. It offers advanced visualization tools, automated analysis, and customizable features, suggesting a focus on intuitive design for medical professionals. Cardiomo, while described as user-friendly with its wearable patch and mobile app, has limited public reviews regarding its ease-of-use, with one review noting 'NaN/5' for ease-of-use.

Clinical Value

cvi42 Auto Imaging

cvi42 Auto Imaging provides comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows, with FDA clearance. Cardiomo offers continuous vital sign monitoring and AI-powered disease detection, with claims of detecting cardiac events with 99.63% accuracy and providing early life-saving alerts. However, many clinical validation studies for AI-integrated wearables are small-scale and short-duration, limiting generalizability.

Pricing & Value

Tie

Both tools require contacting the company for specific pricing, indicating a lack of public transparency. While some estimates for cvi42 Auto Imaging suggest a perpetual license could start around $5,000 for a single user, with higher costs for more users and additional modules, Cardiomo previously offered its device at $200 with a $10 monthly subscription. Without current, publicly available pricing for Cardiomo, a direct comparison of value is difficult, leading to a tie in this dimension.

Enterprise Readiness

cvi42 Auto Imaging

cvi42 Auto Imaging is designed for deployment in on-premise, stand-alone, or networked environments, with cloud compatibility mentioned. It also emphasizes integration with existing systems and workflows, and compliance with hospital IT policies and data protection frameworks. Cardiomo, while HIPAA-compliant and cloud-based, is centered around a wearable device and mobile app, which may present different integration challenges within a large enterprise healthcare system compared to a comprehensive imaging analysis platform.

Innovation

cvi42 Auto Imaging

cvi42 Auto Imaging leverages AI for automated contouring, segmentation, and quantitative analysis across multiple imaging modalities (MR, CT), including advanced features like plaque assessment and 4D flow. Cardiomo's innovation lies in its medical-grade wearable for continuous, remote monitoring and AI-powered disease detection with real-time alerts. However, cvi42's application to complex imaging data and its unified platform approach for anatomy, function, and inflammation represents a broader scope of innovation in diagnostic imaging.

Support & Docs

cvi42 Auto Imaging

cvi42 Auto Imaging offers Email/Help Desk, Phone Support, and 24/7 Live Rep assistance. Circle Cardiovascular Imaging also highlights a commitment to world-class solutions and support, with industry-leading customer satisfaction scores. Information regarding Cardiomo's specific support and documentation is not readily available in the provided data or web search results, making it difficult to assess its offerings in comparison.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature cvi42 Auto Imaging Cardiomo
Name cvi42 Auto Imaging Cardiomo
Company Circle Cardiovascular Imaging Cardiomo, Inc.
Description AI-powered software for comprehensive analysis of cardiovascular MR and CT images, aiding in precise diagnosis, plaque quantification, and streamlined clinical workflows. A medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Key Features AI-enabled automated contouring and segmentation, Cardiac MR analysis (Function, Flow, Tissue Characterization, Strain), Cardiac CT analysis (Calcium Scoring, Coronary Arteries, Plaque Assessment), Vascular CT analysis (diagnosis, planning, surveillance), Quantitative analysis (volume, mass, function, signal intensity, plaque), 3D visualization and multiplanar reconstruction (MPR), Simplified and smart reporting with infographics and CAD-RADS classification, Multi-modality support (MR, CT) and vendor-neutral compatibility Medical-grade wearable patch, Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature), AI-powered disease detection (arrhythmias, cardiovascular events), Real-time alerts and notifications, Mobile application (Android and iOS), HIPAA-compliant cloud analytics, Fall detection, Long battery life (up to 7-10 days)

Videos

Demos, reviews, and walkthroughs featuring cvi42 Auto Imaging and Cardiomo.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

cvi42 Auto Imaging integrates directly into existing PACS and reporting systems like PowerScribe One, aiming to reduce the time from scan to report without requiring expensive HL7 interfaces. Cardiomo, as a wearable device with a mobile app and cloud platform, offers RESTful API, webhooks, and pre-built integrations to connect with existing platforms and can integrate with EHRs to provide continuous patient monitoring data.
cvi42 Auto Imaging's AI models for calcium analysis show classification performance between 86% and 99%, and coronary analysis centerline performance between 82% and 94%, with mask performance between 98% and 100%. Cardiomo's medical-grade wearable device and AI engine are designed to detect cardiac events with 99.63% accuracy and achieve 99.2% clinical accuracy for its sensors, validated through clinical studies.
cvi42 Auto Imaging is designed for Cardiology, Radiology, and Vascular Surgery, offering comprehensive analysis of cardiovascular MR and CT images for precise diagnosis, plaque quantification, and vascular analysis. Cardiomo is suited for Cardiology, Geriatrics, and Internal Medicine, providing continuous and remote heart health monitoring to detect cardiovascular diseases and deliver timely alerts to users and caregivers.
cvi42 is designed with AI-enabled automated contouring and segmentation to simplify and streamline workflows, aiming for ease of use and rapid adoption of advanced analysis. While Cardiomo's mobile application is user-friendly, the learning curve for physicians would primarily involve understanding the remote monitoring platform and integrating continuous vital sign data into their diagnostic and treatment paradigms.
cvi42 Auto Imaging processes all imaging data and results within the customer's secure environment, ensuring no data is transmitted outside the institution, and its AI models are 'frozen' and do not learn from customer data post-deployment. Cardiomo utilizes a HIPAA-compliant cloud analytics system, and its integrations are built with secure authentication using industry-standard OAuth 2.0 and OpenID Connect.
While specific audit-trail features are not explicitly detailed for cvi42, its on-premise deployment and local data management imply that audit capabilities would be managed within the hospital's existing IT infrastructure. For Cardiomo, the cloud-based platform and mobile application would likely incorporate audit trails as part of its HIPAA-compliant analytics system, though specific features are not publicly described.
cvi42's vendor-neutral compatibility and integration with existing PACS systems suggest it can be deployed across multiple sites within a networked environment, ensuring consistent analysis and reporting. Cardiomo's cloud-based platform and mobile app inherently support multi-site rollouts by centralizing data and alerts, allowing for remote monitoring and consistent care coordination across different locations.

Backers

Who funded each tool's parent company.

Cardiomo

AI Tool Finder
AI-powered search. Results may not be comprehensive.